Islet Sciences Report issue

For profit Phase 2
Founded: Raleigh NC United States (2010)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Islet Sciences (0) Acquired (2)

lisofylline (1 trial)

remogliflozin etabonate (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 2